Oscar Health Inc (NYSE:OSCR) shares, rose in value, with the stock price down by -0.21% to the previous day’s close as strong demand from buyers drove the stock to $13.98.
Actively observing the price movement in the last trading, the stock closed the session at $14.01. The value of beta (5-year monthly) was 1.82. Referring to stock’s 52-week performance, its high was $18.55, and the low was $4.72. On the whole, OSCR has fluctuated by 0.50% over the past month.
With the market capitalization of Oscar Health Inc currently standing at about $3.21 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 07, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.27, which is expected to increase to $0.27 for fiscal year -$0.16 and then to about $0.39 by fiscal year 2025. Data indicates that the EPS growth is expected to be 86.90% in 2025, while the next year’s EPS growth is forecast to be 343.80%.
Analysts have estimated the company’s revenue for the quarter at $2.01 billion, with a low estimate of $1.96 billion and a high estimate of $2.05 billion. According to the average forecast, sales growth in current quarter could jump up 75.50%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $8.33 billion, representing an increase of 42.20% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that OSCR’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of OSCR currently trading nearly -1.34% and -5.11% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 46.18, while the 7-day volatility ratio is showing 5.36% which for the 30-day chart, stands at 5.14%. Furthermore, Oscar Health Inc (OSCR)’s beta value is 1.79, and its average true range (ATR) is 0.79.
A comparison of Oscar Health Inc (OSCR) with its peers suggests the former has fared considerably weaker in the market. OSCR showed an intraday change of -0.21% in last session, and over the past year, it grew by 107.42%%.
Data on historical trading for Oscar Health Inc (NYSE:OSCR) indicates that the trading volumes over the past 10 days have averaged 2.36 million and over the past 3 months, they’ve averaged 3.39 million. According to company’s latest data on outstanding shares, there are 193.87 million shares outstanding.
Nearly 36.81% of Oscar Health Inc’s shares belong to company insiders and institutional investors own 45.90% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.31 million shares as on Mar 15, 2024, resulting in a short ratio of 1.87. According to the data, the short interest in Oscar Health Inc (OSCR) stood at 2.75% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 5.26 million. The stock has risen by 52.79% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the OSCR stock heading into the next quarter.
